STUDY OF 2 CONTROLLED-RELEASE THEOPHYLLINE PREPARATIONS

被引：8

作者：

FINK, JN ^{[1
]}

LEVY, MB ^{[1
]}

CONRAD, E ^{[1
]}

机构：

[1] PURDUE FREDERICK CO,NORWALK,CT

来源：

AMERICAN JOURNAL OF MEDICINE | 1985年 / 79卷 / 6A期

关键词：

D O I：

10.1016/0002-9343(85)90090-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：58 / 61

页数：4

共 14 条

[1]

BELL T, 1978, PEDIATRICS, V62, P352

[2] SERUM PROFILE AND BIOAVAILABILITY OF A CONTROLLED-RELEASE THEOPHYLLINE FORMULATION FOR ONCE-DAILY USE - COMPARISON WITH A 12-HR PREPARATION [J].

COHEN, BM .

JOURNAL OF ASTHMA, 1984, 21 (05) :305-309

[3] COMPARISON OF STANDARD-RELEASE AND SUSTAINED-RELEASE THEOPHYLLINE TABLETS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].

DASTA, J ;

MIRTALLO, JM ;

ALTMAN, M .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (05) :613-617

[4]

HENDELES L, 1978, AM J DIS CHILD, V132, P876

[5] A CLINICAL AND PHARMACOKINETIC BASIS FOR THE SELECTION AND USE OF SLOW RELEASE THEOPHYLLINE PRODUCTS [J].

HENDELES, L ;

IAFRATE, RP ;

WEINBERGER, M .

CLINICAL PHARMACOKINETICS, 1984, 9 (02) :95-135

[6] ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE [J].

HENDELES, L ;

WEINBERGER, M ;

BIGHLEY, L .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05) :525-527

[7]

HORODNIAK J, COMMUNICATION

[8] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY [J].

JACOBS, MH ;

SENIOR, RM ;

KESSLER, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18) :1983-1986

[9]

MITENKO PA, 1974, CLIN PHARMACOL THER, V16, P720

[10]

RALL TW, 1980, PHARMACOL BASIS THER, P602

← 1 2 →